{"id":"https://openalex.org/W4200549171","doi":"https://doi.org/10.1158/1535-7163.targ-21-p215","title":"Abstract P215: The MDM2 inhibitor milademetan induces synthetic lethality in GATA3 mutant, ER positive breast cancer","display_name":"Abstract P215: The MDM2 inhibitor milademetan induces synthetic lethality in GATA3 mutant, ER positive breast cancer","publication_year":2021,"publication_date":"2021-12-01","ids":{"openalex":"https://openalex.org/W4200549171","doi":"https://doi.org/10.1158/1535-7163.targ-21-p215"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.targ-21-p215","doi":"https://doi.org/10.1158/1535-7163.targ-21-p215","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.targ-21-p215","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037183800","display_name":"Vijaya G. Tirunagaru","orcid":"https://orcid.org/0000-0002-6505-8858","observed_orcids":["https://orcid.org/0000-0002-6505-8858"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vijaya G. Tirunagaru","raw_affiliation_strings":["1Rain Therapeutics, Newark, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Rain Therapeutics, Newark, CA,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051220930","display_name":"Gaia Bianco","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1850255","display_name":"University of Basel","ror":"https://ror.org/02s6k3f65","country_code":"CH","type":"education","lineage":["https://openalex.org/I1850255"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Gaia Bianco","raw_affiliation_strings":["2University of Basel, Basel, Switzerland,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University of Basel, Basel, Switzerland,","institution_ids":["https://openalex.org/I1850255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057848295","display_name":"Charlotte K.Y. Ng","orcid":"https://orcid.org/0000-0002-6100-0026","observed_orcids":["https://orcid.org/0000-0002-6100-0026"]},"institutions":[{"id":"https://openalex.org/I118564535","display_name":"University of Bern","ror":"https://ror.org/02k7v4d05","country_code":"CH","type":"education","lineage":["https://openalex.org/I118564535"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Charlotte K. Y. Ng","raw_affiliation_strings":["3University of Bern, Bern, Switzerland,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3University of Bern, Bern, Switzerland,","institution_ids":["https://openalex.org/I118564535"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059398124","display_name":"Elisabetta Marangoni","orcid":"https://orcid.org/0000-0002-3337-6448","observed_orcids":["https://orcid.org/0000-0002-3337-6448"]},"institutions":[{"id":"https://openalex.org/I80043","display_name":"Institut Curie","ror":"https://ror.org/04t0gwh46","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I80043"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Elisabetta Marangoni","raw_affiliation_strings":["4Institut Curie, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Institut Curie, Paris, France","institution_ids":["https://openalex.org/I80043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051087530","display_name":"Salvatore Piscuoglio","orcid":"https://orcid.org/0000-0003-2686-2939","observed_orcids":["https://orcid.org/0000-0003-2686-2939"]},"institutions":[{"id":"https://openalex.org/I1850255","display_name":"University of Basel","ror":"https://ror.org/02s6k3f65","country_code":"CH","type":"education","lineage":["https://openalex.org/I1850255"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Salvatore Piscuoglio","raw_affiliation_strings":["2University of Basel, Basel, Switzerland,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University of Basel, Basel, Switzerland,","institution_ids":["https://openalex.org/I1850255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005286764","display_name":"Fran\u00e7ois\u2010Cl\u00e9ment Bidard","orcid":"https://orcid.org/0000-0001-5932-8949","observed_orcids":["https://orcid.org/0000-0001-5932-8949"]},"institutions":[{"id":"https://openalex.org/I80043","display_name":"Institut Curie","ror":"https://ror.org/04t0gwh46","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I80043"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Fran\u00e7ois-Cl\u00e9ment Bidard","raw_affiliation_strings":["4Institut Curie, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Institut Curie, Paris, France","institution_ids":["https://openalex.org/I80043"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034705456","display_name":"Robert Charles Doebele","orcid":"https://orcid.org/0000-0001-6728-6857","observed_orcids":["https://orcid.org/0000-0001-6728-6857"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert C. Doebele","raw_affiliation_strings":["1Rain Therapeutics, Newark, CA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Rain Therapeutics, Newark, CA,","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"20","issue":"12_Supplement","first_page":"P215","last_page":"P215"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.004699999932199717,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/milademetan","display_name":"milademetan","score":0.8539999723434448},{"id":"https://openalex.org/keywords/mdm2-inhibitors","display_name":"MDM2 inhibitors","score":0.9259999990463257},{"id":"https://openalex.org/keywords/synthetic-lethality","display_name":"synthetic lethality","score":0.9269999861717224},{"id":"https://openalex.org/keywords/gata3-mutations","display_name":"GATA3 mutations","score":0.9580000042915344},{"id":"https://openalex.org/keywords/estrogen-receptor-positive-breast-cancer","display_name":"estrogen receptor-positive breast cancer","score":0.9459999799728394},{"id":"https://openalex.org/keywords/frameshift-mutation","display_name":"frameshift mutation","score":0.6520000100135803},{"id":"https://openalex.org/keywords/patient-derived-organoids","display_name":"patient-derived organoids","score":0.7789999842643738},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.949999988079071},{"id":"https://openalex.org/keywords/fulvestrant-resistance","display_name":"fulvestrant resistance","score":0.8830000162124634},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.609000027179718},{"id":"https://openalex.org/keywords/mcf-7-cells","display_name":"MCF-7 cells","score":0.8059999942779541},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.7599999904632568},{"id":"https://openalex.org/keywords/survival-analysis","display_name":"survival analysis","score":0.4440000057220459},{"id":"https://openalex.org/keywords/the-cancer-genome-atlas","display_name":"TCGA","score":0.5410000085830688}],"concepts":[{"id":"https://openalex.org/C2778502085","wikidata":"https://www.wikidata.org/wiki/Q7662767","display_name":"Synthetic lethality","level":4,"score":0.7410153150558472},{"id":"https://openalex.org/C102037460","wikidata":"https://www.wikidata.org/wiki/Q18025464","display_name":"GATA3","level":4,"score":0.7310662269592285},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6852318048477173},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6638537049293518},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5857709646224976},{"id":"https://openalex.org/C173396325","wikidata":"https://www.wikidata.org/wiki/Q1501275","display_name":"Gene knockdown","level":3,"score":0.557266354560852},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.5183175802230835},{"id":"https://openalex.org/C119056186","wikidata":"https://www.wikidata.org/wiki/Q1431332","display_name":"Gene silencing","level":3,"score":0.5018820762634277},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4786970913410187},{"id":"https://openalex.org/C29906990","wikidata":"https://www.wikidata.org/wiki/Q1440688","display_name":"Frameshift mutation","level":4,"score":0.46353769302368164},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.45284736156463623},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.4178536534309387},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4134840965270996},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.3549916744232178},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.29587167501449585},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.15527915954589844},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1104646623134613},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.06750920414924622},{"id":"https://openalex.org/C86339819","wikidata":"https://www.wikidata.org/wiki/Q407384","display_name":"Transcription factor","level":3,"score":0.060844361782073975}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.targ-21-p215","doi":"https://doi.org/10.1158/1535-7163.targ-21-p215","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.targ-21-p215","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8399999737739563}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4225768539","https://openalex.org/W4282982745","https://openalex.org/W4322769764","https://openalex.org/W2943992466","https://openalex.org/W4410844740","https://openalex.org/W4411287126","https://openalex.org/W3170326664","https://openalex.org/W2514386502","https://openalex.org/W4379328135","https://openalex.org/W2766401022"],"abstract_inverted_index":{"Abstract":[0],"GATA3":[1,18,32,64,93,108,206,302,321,338,351,387],"is":[2,165],"mutated,":[3],"predominantly":[4],"via":[5],"frameshift":[6],"(fs)":[7],"mutations,":[8],"in":[9,62,92,106,125,136,148,188,210,224,251,257,288,301,320,331,349,386],"15-18%":[10],"of":[11,23,40,55,73,81,90,103,134,178,185,191,197,205,240,276,293,328,347,396],"estrogen":[12],"receptor":[13],"(ER)-positive":[14],"breast":[15,67,96,110,126,211,259,304,323,335,353,391],"cancers":[16],"and":[17,129,147,153,168,193,215,263,271,287,306,405],"mutations":[19,33,207],"define":[20],"a":[21,58,63,116,264,268],"subset":[22],"patients":[24,128],"with":[25,309,337],"poor":[26],"response":[27],"to":[28,52,77,169,230,249,283,317,356],"hormonal":[29],"therapy.":[30],"Importantly,":[31],"are":[34],"not":[35],"currently":[36],"targetable.":[37],"Computational":[38],"analysis":[39],"the":[41,44,53,79,101,131,162,174,183,189,195,203,238,294,397],"data":[42,291,341],"from":[43],"large-scale,":[45],"deep":[46],"RNAi":[47],"screen":[48],"project":[49],"DRIVE":[50],"led":[51],"identification":[54],"MDM2":[56,91,104,186,241,314,380],"as":[57,234],"synthetic":[59,163,318,384],"lethal":[60],"partner":[61],"mutant":[65,94,109,303,322,352],"ER+":[66,95,258,334],"cancer":[68,111,127,212,260,305,354,392],"cell":[69,112,139,222,244],"line.":[70],"The":[71,379],"objective":[72],"this":[74,170],"study":[75],"was":[76,228,246],"evaluate":[78],"activity":[80,133,282,330],"milademetan":[82,135,179,250,256,284,348,382],"(RAIN-32),":[83],"an":[84],"orally":[85],"available,":[86],"small":[87],"molecule":[88],"inhibitor":[89,381],"cancer.":[97],"Here,":[98],"we":[99,159,172,201,254],"evaluated":[100,202],"effect":[102,184,227,239],"silencing":[105,219],"ER+,":[107,350],"line":[113,245],"MCF-7":[114,243],"harboring":[115,267],"loss-of-function":[117],"mutation":[118,270],"(p.D335Gfs)":[119],"that":[120,161],"has":[121],"been":[122],"recurrently":[123],"observed":[124],"tested":[130,255],"antitumoral":[132],"vitro":[137],"(MCF-7":[138],"line)":[140],"ex":[141,285],"vivo":[142,149,286],"(patient":[143],"derived":[144],"organoids;":[145],"PDO)":[146],"(cell":[150],"line-derived":[151],"xenograft":[152,155],"patient-derived":[154],"(PDX)":[156],"models).":[157],"Additionally,":[158],"hypothesized":[160],"lethality":[164,319,385],"p53":[166,175,192,232,235],"dependent":[167,176,233],"aim":[171],"explored":[173],"effects":[177],"inhibition":[180],"by":[181],"determining":[182],"loss":[187],"absence":[190],"analyzing":[194],"expression":[196],"p53-target":[198],"genes.":[199],"Finally,":[200,253],"impact":[204],"on":[208,402],"survival":[209,300],"using":[213],"TCGA":[214],"AACR":[216],"Genie":[217],"datasets.MDM2":[218],"significantly":[220],"reduced":[221],"proliferation":[223],"MCF-7.":[225],"This":[226],"shown":[229],"be":[231],"knockdown":[236],"reversed":[237],"loss.":[242],"also":[247],"sensitive":[248],"vitro.":[252],"models":[261,278],"(PDO":[262],"fulvestrant-resistant":[265],"PDX)":[266],"GATA3fs":[269],"wild":[272],"type":[273],"TP53.":[274],"Treatment":[275],"these":[277],"displayed":[279],"dose-dependent":[280],"anti-tumor":[281],"vivo.":[289],"Sequencing":[290],"analyses":[292],"publicly":[295],"available":[296],"datasets":[297],"revealed":[298],"lower":[299],"mutual":[307],"exclusivity":[308],"TP53":[310],"mutations.":[311,339],"In":[312],"conclusion,":[313],"deficiency":[315],"leads":[316],"cancers.":[324],"Milademetan":[325],"shows":[326],"evidence":[327,343],"antitumor":[329],"genetically":[332],"selected":[333],"tumors":[336],"These":[340],"provide":[342],"for":[344],"clinical":[345],"exploration":[346],"refractory":[355],"current":[357],"therapies.":[358],"Citation":[359],"Format:":[360],"Vijaya":[361],"G.":[362],"Tirunagaru,":[363],"Gaia":[364],"Bianco,":[365],"Charlotte":[366],"K.":[367],"Y.":[368],"Ng,":[369],"Elisabetta":[370],"Marangoni,":[371],"Salvatore":[372],"Piscuoglio,":[373],"Fran\u00e7ois-Cl\u00e9ment":[374],"Bidard,":[375],"Robert":[376],"C.":[377],"Doebele.":[378],"induces":[383],"mutant,":[388],"ER":[389],"positive":[390],"[abstract].":[393],"In:":[394],"Proceedings":[395],"AACR-NCI-EORTC":[398],"Virtual":[399],"International":[400],"Conference":[401],"Molecular":[403],"Targets":[404],"Cancer":[406,415],"Therapeutics;":[407],"2021":[408],"Oct":[409],"7-10.":[410],"Philadelphia":[411],"(PA):":[412],"AACR;":[413],"Mol":[414],"Ther":[416],"2021;20(12":[417],"Suppl):Abstract":[418],"nr":[419],"P215.":[420]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2021-12-31T00:00:00"}